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It is unclear how the mitochondrial fusion protein Optic atrophy 1 (OPA1), which inhibits
cristae remodeling, protects from mitochondrial dysfunction. Here we identify the mito-
chondrial F1Fo-ATP synthase as the effector of OPA1 in mitochondrial protection. In OPA1
overexpressing cells, the loss of proton electrochemical gradient caused by respiratory chain
complex III inhibition is blunted and this protection is abolished by the ATP synthase inhibitor
oligomycin. Mechanistically, OPA1 and ATP synthase can interact, but recombinant OPA1
fails to promote oligomerization of purified ATP synthase reconstituted in liposomes, sug-
gesting that OPA1 favors ATP synthase oligomerization and reversal activity by modulating
cristae shape. When ATP synthase oligomers are genetically destabilized by silencing the key
dimerization subunit e, OPA1 is no longer able to preserve mitochondrial function and cell
viability upon complex III inhibition. Thus, OPA1 protects mitochondria from respiratory chain
inhibition by stabilizing cristae shape and favoring ATP synthase oligomerization.
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Cristae are a pleomorphic subcompartment of the innermitochondrial membrane (IMM) essential for biologicalenergy conversion and for regulation of mitochondrial
apoptosis1. Cristae shape and mitochondrial function are inti-
mately connected2: changes in cristae morphology affect stability
of respiratory supercomplexes (RCS)3,4, functional quaternary
assemblies of respiratory chain complexes (RCC)1,5–8. In a
reductionist view, cristae shape can be defined by the curvature of
two regions: the cristae junctions (CJs), narrow tubular structures
connecting cristae to the inner boundary membrane9; and the
cristae lumen proper. CJs limit the diffusion of cytochrome c
from the cristae10,11 and their enlargement (i.e., the transition
from the negative curvature of a shape resembling a solid
hyperboloid to the null curvature of a cylinder or to the positive
curvature of a spheroid) triggered by proapoptotic BH3-only
BCL-2 family members BID, BIM-S, or BNIP3 allows cytochrome
c redistribution10,12–14. During this process of cristae remodeling,
cristae lumen width is also altered: the transition to a more
positive CJ curvature results in overall cristae widening. Func-
tionally, cristae widening destabilizes RCS and reduces mito-
chondrial oxidative phosphorylation efficiency3. In sum, cristae
shape is a key morphological parameter that influences mito-
chondrial apoptosis and respiration.
A central modulator of cristae curvature is the IMM dynamin-
related protein Optic atrophy 1 (OPA1): OPA1 oligomers
maintain a negative CJ curvature, controlling cytochrome c
redistribution and release11,13 and stabilizing RCS to increase
respiratory efficiency3,4,15. Because of these pleiotropic effects on
mitochondrial function, controlled OPA1 overexpression is ben-
eficial against a variety of pathological conditions, ranging from
ischemia-reperfusion to massive hepatocellular apoptosis to
muscular atrophy4, and even to deletion of genes essential for
assembly of RCC15. This remarkable protective effect suggests
that OPA1 does not work alone in the regulation of mitochon-
drial structure and hence function.
Other key players in cristae morphology include the MICOS
complex, a multiprotein structure conserved from yeast to
mammals16 and the mitochondrial F1Fo-ATP synthase, whose
oligomers are retrieved on the edges of the cristae and contribute
to define cristae curvature17–25. In mammals, OPA1 and the core
MICOS component Mic60 physically interact and cooperate to
stabilize the negative CJs curvature; however, CJ and cristae
diameter, the key parameters defining mitochondrial apoptosis
and respiration, are solely controlled by OPA126, ruling out a role
for MICOS in the mitochondrial protection afforded by OPA1.
Another potential candidate is the mitochondrial ATP synthase
that also can physically interact with OPA127,28. The ATP syn-
thase utilizes the mitochondrial proton electrochemical gradient
(ΔμH+) generated by the RCC1,29,30 to recycle ATP from ADP
and Pi 31,32. This enzyme also forms the permeability transition
pore (PTP)33, a large conductance channel whose prolonged
openings collapse ΔμH+ and cause cell death. Finally, the ATP
synthase can also sustain the ΔμH+ when RCC are inhibited, by
running in its reverse mode, hydrolyzing ATP to pump protons
across the IMM32.
However, the interplay between ATP synthase and OPA1 in
mitochondrial ultrastructure and function is unclear. Here, we
provide evidence that OPA1 requires ATP synthase oligomers to
protect mitochondria from respiratory chain inhibition.
Results
OPA1 counteracts mitochondrial dysfunction by antimycin A.
OPA1 overexpression is beneficial in vivo against primary and
secondary mitochondrial dysfunction4,15 because of its ability to
blunt mitochondrial apoptosis11 and to promote RCS stability3.
However, the extent and mechanism of this mitochondrial pro-
tection are unclear. We therefore capitalized on models of Opa1
mild overexpression and conditional ablation to investigate in real
time how OPA1 levels influenced the mitochondrial electro-
chemical gradient in response to complex III blockage by the
inhibitor antimycin A (AA)34,35.
In mouse adult fibroblasts (MAFs) from Opa1 transgenic
(Opa1tg) mice, OPA1 levels and oligomers were 1.5-fold higher
(Supplementary Fig. 1a, b) and cristae accordingly ~30%
narrower (Supplementary Fig. 1c, d), as previously reported3.
Real-time measurements of the fluorescence of the potentiometric
dye tetramethylrhodamine methylester (TMRM) indicated that
Opa1tg MAFs were surprisingly protected by AA-induced
mitochondrial depolarization (Fig. 1a, b). We further tested
whether OPA1 was able to prevent matrix acidification in the
same experimental conditions, by measuring matrix pH with
mtSypHer, a ratiometric genetically encoded pH sensor targeted
to the mitochondrial matrix34. Matrix pH was superimposable in
WT and Opa1tg MAFs, irrespective of whether the cells were
cultured in media containing glucose or galactose (to force
mitochondrial ATP production, Supplementary Fig. 1e). Real-
time mtSypHer imaging indicated that OPA1 overexpression
blunted also the matrix acidification caused by AA (Fig. 1c, d).
We next turned to Opa1flx/flx MAFs where 48 h after transfection
with CRE recombinase OPA1 was almost completely absent
(Supplementary Fig. 2). In this same timeframe, Opa1 deletion
does not modify mitochondrial DNA (mtDNA) content or
translation1,3,36. Real-time mtSypHer imaging revealed that
matrix acidification induced by AA was more severe upon
Opa1 deletion (Fig. 1e, f). Thus, OPA1 protects from electro-
chemical gradient loss upon CIII blockage.
OPA1 sustains mitochondrial function via ATP synthase
activity. We wondered how a dynamin-related protein involved
in cristae morphogenesis and membrane fusion could regulate
mitochondrial electrochemical gradient. Because reversal of ATP
synthase activity can sustain mitochondrial membrane potential
upon RCC inhibition37, we tested if OPA1 facilitated reversal
ATP synthase activity to extrude protons from the matrix and
maintain ΔμH+. The protective effect of OPA1 overexpression on
AA-induced matrix acidification and depolarization was fully
abolished by the ATP synthase inhibitor oligomycin (Fig. 2a–d).
Oligomycin also equalized AA-induced pH changes in empty
vector (EV) and CRE-transfected Opa1flx/flx cells (Fig. 2e, f). The
effects of OPA1 on pH could be a consequence of decreased
proton leak, or of increased proton pumping by the reversal mode
of the ATP synthase. If proton leak were reduced in Opa1tg
MAFs, ATP synthase inhibition would result in a higher ΔμH+
compared to WT cells. However, membrane potential and matrix
pH changes were superimposable in WT and Opa1tg MAFs
treated with oligomycin (Supplementary Fig. 3a-c), indicating a
similar proton leak in these two cell lines. Thus, the differences in
ΔμH+ upon CIII inhibition recorded in WT and Opa1tg MAFs
could be due to different stimulation of the reversal ATP synthase
activity.
To directly measure if OPA1 affected ATP synthase activity
in situ, we monitored ATP synthase-dependent hydrolysis of
mitochondrial ATP upon complex III inhibition in real time in
living cells. The FRET probe ATeam1.0338 was correctly targeted
to the mitochondrial matrix and revealed that basal mitochon-
drial ATP content was similar in WT and Opa1tg MAFs
(Supplementary Fig. 3d). Following complex III inhibition,
ATeam1.03 fluorescence decayed 3-fold faster in Opa1tg MAFs,
suggesting faster ATP hydrolysis. These fluorescence changes
were indeed due to ATP synthase activity, because they were
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abolished by the ATP synthase inhibitor oligomycin (Fig. 2g–i
and Supplementary Movie 1). Notably, oligomycin did not affect
OPA1 oligomerization in WT or Opa1tg MAFs (Supplementary
Fig. 4). Thus, OPA1 overexpression stimulates reversal ATP
synthase activity.
OPA1 stabilizes ATP synthase oligomers. How does OPA1
overexpression impinge on ATP synthase to protect mitochon-
dria from AA? Because OPA1 overexpression favors
mitochondrial RCS assembly by impinging on cristae shape3, we
verified if the same was also true for ATP synthase oligomer-
ization. Blue Native Gel Electrophoresis (BNGE) indicated that
oligomeric ATP synthase was stabilized in mitochondria from
Opa1tg cells (Fig. 3a, b). When we acutely deleted Opa1 by
expressing Cre recombinase in Opa1flx/flx MAFs, ATP synthase
dimers and monomers were less abundant, with an increase in
free F1 subunit and a reduction in ATP synthase activity and total
protein levels (Fig. 3c–e). Thus, OPA1 levels correlate with ATP
synthase oligomerization and stability.
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We next verified if OPA1 could stabilize ATP synthase
oligomers also during apoptotic cristae shape changes induced
by the caspase-8 cleaved, active form of the proapoptotic Bcl-2
family member BID. To this end, we compared the effects on
ATP synthase levels and oligomerization of WT BID, of a BID
mutant (BIDKKAA) that permeabilizes the mitochondrial outer
membrane (OMM) but does not remodel cristae3 and of an
OMM-permeabilization deficient BID mutant (BIDG94E) that
causes cristae remodeling but not cytochrome c release3,39. While
total levels of ATP synthase were not affected by treatment of WT
or Opa1tg mitochondria with the different BID mutants (Fig. 3f,
g), BID and BIDG94E destabilized ATP synthase oligomers only in
WT mitochondria. As expected, treatment with the cristae
remodeling deficient BIDKKAA mutant did not affect the ATP
synthase oligomerization pattern (Fig. 3f, h).
To further corroborate these biochemical experiments, we
turned to an approach of proteomic profiling of high molecular
weight (HMW) complexes (complexomic) that allowed us to
identify dynamic changes of MICOS during cristae remodeling26.
We therefore performed a similar analysis focused on ATP
synthase complexes. First, we confirmed by immunoblotting and
complexomic analysis of native protein complexes separated by
BNGE from purified heart mitochondria that treatment with WT
BID, but not BIDKKAA, caused the disassembly of OPA1-
containing HMW complexes26 (Fig. 4a–c). We next focused our
attention on the oligomeric ATP synthase assemblies. We found
that in the BNGE regions corresponding to ATP synthase dimers
and oligomers, the spectral counts corresponding to the F1 core
subunits ATP5A (α), ATP5B (β), ATP5C1 (γ), ATP5D (δ) and
ATP5O (OSCP; see details on the analyzed subunits in
supplementary Data 1) were reduced in mitochondria treated
with WT BID but not with BIDKKAA (Fig. 4d). The accuracy of
this complexomic profiling was further supported by the analysis
of the ATP5K (e) subunit essential for ATP synthase dimeriza-
tion40–43: ATP5K was retrieved only in the BNGE region
corresponding to dimers and its spectral counts dropped to
~40% of control mitochondria upon BID-treatment; the drop was
caused by cristae remodeling, because the spectral counts
remained ~72% of the untreated in mitochondria challenged
with BIDKKAA (Fig. 4e), as further confirmed by immunoblotting
(Fig. 4f). Overall, the analysis of the median of ATP synthase
subunits spectral counts confirmed that ATP synthase dimers and
oligomers were reduced in BID- but not in BIDKKAA-treated
mitochondria (Fig. 4g). In conclusion, independent biochemical
approaches indicate that ATP synthase oligomers are stabilized
upon OPA1 overexpression and destabilized when Opa1 is
deleted, or cristae remodeled with concomitant OPA1 HMW
oligomers disassembly.
OPA1 does not directly stimulate ATP synthase oligomeriza-
tion. Because OPA1 levels are proportional to ATP synthase
oligomerization, we wished to understand how OPA1 sustained
ATP synthase oligomerization. Levels of the ATP synthase inhi-
bitory factor (IF1), whose oligomerization is influenced by matrix
pH44 and that in its oligomeric form can stabilize ATP synthase
dimers45, were similar in WT and Opa1tg MAFs (Supplementary
Fig. 5), suggesting that other mechanisms were in place.
We first asked whether OPA1 could directly interact with ATP
synthase. Chemical crosslinking using 1-Ethyl-3-(3-dimethylami-
nopropyl)carbodiimide hydrochloride (EDC) resulted in the
appearance of a ~130 KDa band immunoreactive for both
ATP5B (β-subunit) and OPA1 (Fig. 5a). Moreover, ATP5B and
OPA1 reciprocally co-immunoprecipitated (Fig. 5b, c), confirm-
ing and extending previous results that identified several ATP
synthase subunits as OPA1 interactors28. To verify if OPA1 could
also directly promote or stabilize the oligomeric forms of ATP
synthase, we turned to an in vitro system of purified proteins and
liposomes. We prepared proteoliposomes containing highly pure
ATP synthase stabilized in the high affinity lipid like detergent
Lauryl Maltose Neopentyl Glycol, as confirmed by EM (Fig. 5d).
We also established a protocol to produce and purify a
recombinant form of soluble OPA1 (lacking the import sequence
and the transmembrane domain, supplementary Figure 6a) by
adding a 6-His-Tag to its C-terminus. Following induction of
expression in competent bacteria we purified recombinant soluble
OPA1 (rOPA1) by affinity chromatography on Ni-NTA beads.
Since a contaminant protein with ATPase activity bound to
rOPA1, we removed it by extensive washes with ATP, before we
eluted by increasing imidazole concentrations obtaining moderate
yields of rOPA1 devoid of the contaminating ATPase activity
(Supplementary Fig. 6b). Enzymatic activity of the dialyzed
rOPA1 determined by reverse phase chromatography was in the
range of other dynamin-related GTPases, confirming that rOPA1
was active and stable. We therefore incorporated rOPA1 into the
proteoliposome lumen, mimicking the relative topology of OPA1
and ATP synthase in mitochondria (Supplementary Fig. 6c).
When we analyzed these proteoliposomes by BNGE, we did not
observe any effect of rOPA1 on ATP synthase oligomerization
(Fig. 5e, f). In a further in vitro experiment, we added increasing
concentrations of rOPA1 to native purified ATP synthase in a
digitonin based buffer. However, also in these conditions rOPA1
failed to stimulate ATP synthase dimerization; if anything, in the
presence of rOPA1, ATP synthase was mostly monomeric
(Fig. 5g, h). Thus, despite its interaction with ATP synthase
subunits, OPA1 does not directly stimulate or stabilize ATP
synthase oligomerization.
OPA1 sustains mitochondrial function via ATPase oligomers.
In Opa1tg mitochondria ATP synthase oligomers are more
abundant and matrix pH is maintained upon complex III inhi-
bition. We therefore turned to a genetic approach to test whether
OPA1 required ATP synthase oligomers to protect from
Fig. 1 OPA1 prevents mitochondrial electrochemical gradient loss caused by CIII inhibition. a Representative color-coded frames from real time imaging of
TMRM fluorescence in MAFs of the indicated genotype. Where indicated, cells were treated for 30min with 10 µM antimycin A (AA). Scale bar, 20 µm.
b Quantitative analysis of TMRM fluorescence over mitochondrial regions in real time imaging experiments as in a. Where indicated, cells were treated
with AA (10 µM) and with FCCP (2 µM). Data are average ± SEM. (n= 5 for each group). c Representative color-coded frames from real time imaging of
mtSypHer fluorescence ratio in MAFs of the indicated genotype. Where indicated, cells were treated for 30min with 10 µM AA. Rainbow color bar:
pseudocolor scale of mtSypHer fluorescence ratio. Scale bar, 20 µm. d Quantitative analysis of mitochondrial mtSypHer fluorescence ratio in real time
imaging experiments as in c. Where indicated, cells were treated with AA (10 µM). Data are mean ± SEM of at least four independent experiments.
e Representative color-coded images of mitochondrial mtSypHer fluorescence in Opa1flx/flx cells transfected with empty (EV) or CRE-encoding vectors and
treated where indicated for 30min with AA (10 µM). Rainbow color bar: pseudocolor scale of SypHer fluorescence ratio. Scale bar, 20 µm. f Quantitative
analysis of mitochondrial mtSypHer fluorescence ratio in real time imaging experiments as in a. Data are mean ± SEM of at least four different experiments
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mitochondrial CIII blockage. ATP synthase subunit e (ATP5k) is
required for ATP synthase dimerization40–43, but its ablation does
not compromise monomer function40,46,47. Efficient ATP5k
silencing in WT and Opa1tg MAFs (Fig. 6a) yielded a super-
imposable reduction in ATP synthase dimers/total ATP synthase
ratio (Fig. 6b, c)41. Because subunit e downregulation causes
mitochondrial ultrastructural defects19,24,48, we inspected cristae
shape in ATP5k silenced mitochondria. We morphometrically
evaluated three parameters: cristae width, cristae number, and the
ratio between CJ and cristae number, an indicator of the presence
of arched or septate cristae, i.e., cristae connecting the IMM at
two or more CJ. While ATP5k downregulation did not affect
cristae width (Fig. 6d, e), it reduced cristae number and it
increased the CJ/cristae number ratio (Fig. 6d, f, g), indicating the
formation of arched and septate cristae with less tips41. In Opa1tg
MAFs the formation of these arched/septate cristae was blunted
(Fig. 6g). Interestingly, ATP5k silencing reduced OPA1 oligomers
in WT but not in Opa1tg MAFs (Supplementary Fig. 7a, b),
suggesting that the formation of arched cristae caused by ATP5k
silencing in WT cells depends on disassembly of OPA1 oligomers
that are more stable upon OPA1 overexpression4,11. Our results
indicate that OPA1 can compensate for the ultrastructural defects
caused by reduced ATP synthase dimerization. A diametrically
different scenario emerged when we delved into the mechanism
of Opa1tg cells protection from AA-induced mitochondrial
depolarization. ATP5k downregulation did not reduce resting
ATP content in WT or Opa1tg cells (Supplementary Fig. 8a)40,47.
Conversely, it completely abolished the effect of OPA1 on pro-
tection from AA-induced depolarization (Fig. 7a–c and Supple-
mentary Movie 2), as well as on stimulation of ATPase reversal



































































































































































Fig. 2 OPA1 requires ATP synthase activity to prevent mitochondrial ΔpH loss caused by CIII inhibition. a Representative color-coded frames from real time
imaging of mtSypHer ratio fluorescence in MAFs of the indicated genotype. Where indicated, cells were incubated with oligomycin (oligo, 1 µM for 30min)
and antimycin A (AA) (10 µM added 5min after oligo, for 25 min). Rainbow color bar: pseudocolor scale of SypHer fluorescence ratio. Scale bar, 20 µm.
b Quantitative analysis of mitochondrial mtSypHer fluorescence ratio in real time imaging experiments as in a. Data are mean ± SEM of at least four
independent experiments. c Representative pseudocolor-coded frames from real time imaging of TMRM fluorescence in MAFs of the indicated genotype.
Where indicated, cells were incubated with oligomycin (1 µM for 5min, before AA additions) and AA (2 µM for 25min). Scale bar, 20 µm. d Quantitative
analysis of mitochondrial TMRM fluorescence ratio in real time imaging experiments as in c. Where indicated, cells were treated with 2 µM carbonyl
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP). Data are mean ± SEM of at least four independent experiments. e Representative color-coded
images of mitochondrial mtSypHer fluorescence in Opa1flx/flx cells transfected with empty (EV) or Cre-encoding vectors and treated for 30min with AA
(10 µM) and oligomycin (1 µM, added 5min before AA) where indicated. Rainbow color bar: pseudocolor scale of mtSypHer fluorescence ratio. Scale bar,
20 µm. f Quantitative analysis of mitochondrial mtSypHer fluorescence ratio in real time imaging experiments as in e. Data are mean ± SEM of at least 4
independent experiments. g Pseudocolor-coded frames of mtATeam FRET fluorescence ratio in cells of the indicated genotype. Where indicated, cells were
treated for 10min with AA (10 µM). Rainbow color bar: pseudocolor scale of ATeam fluorescence ratio. Scale bar, 20 µm. h Quantitative analysis of
mitochondrial mtATeam fluorescence ratio in real time imaging experiments as in g. Data are mean ± SEM of at least three independent experiments.
iMean ± SEM of mtATeam fluorescence ratio slopes, calculated from experiments as in g. Where indicated, oligomycin (1 µM) was added 5 min before AA.
*p < 0.05 in an unpaired two-sample Student’s t test
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function, measured by following matrix ATP hydrolysis in real
time (Fig. 7d, e; Supplementary Fig. 8b). Thus, OPA1 requires
ATP5k and hence efficient ATP synthase dimerization to protect
from mitochondrial dysfunction. If this model was correct,
OPA1 should inhibit cell death induced by complex III inhibition
and ATP5k should be essential for this cytoprotective effect.
Indeed, WT MAFs grown in galactose-containing media rapidly
died when challenged with AA, whereas Opa1tg MAFs were
protected; downregulation of ATP5k equalized death levels
between Opa1tg and WT cells (Fig. 7f). Our results indicate that
the protection provided by OPA1 overexpression requires ATP5K
and efficient ATP synthase oligomerization to sustain mito-
chondrial ΔpH and curtail cell death following complex III
Inhibition.
Discussion
How the IMM fusion and cristae biogenesis protein OPA1 pre-
serve mitochondrial function from a plethora of tissue-damaging
insults and from respiratory chain inhibition is unclear. Here,
multiple lines of evidence point to a key role for ATP synthase
oligomerization status and reversal (i.e., ATP hydrolase) activity.
OPA1 overexpression counteracts multiple insults including
ischemia, atrophy and death-receptor mediated apoptosis that
converge on mitochondria4,49, and most remarkably it corrects
electron transport chain defects in vivo15. Part of its protective
action can be attributed to the inhibition of the apoptotic cristae
remodeling pathway, resulting in reduced cytochrome c release
and apoptosis10,12–14, but how OPA1 improves mitochondrial
function when RCC are genetically impaired is less clear. Negative
cristae, i.e., concave curvature at cristae junctions, correlate with
increased RCS stability and increased residual RCC function15.
While this could explain the correction of mitochondrial function
in mitochondria lacking the complex IV assembly factor Cox15, it
does not explain the improvement observed in mice where the
essential complex I subunit Ndufs4 is deleted15. Our results
indicate that cristae shaping by OPA1 fosters ATP synthase oli-
gomers and reversal activity, providing a unifying mechanism for

















































































































































































































































Fig. 3 OPA1 promotes stabilization of ATP synthase oligomers. a Equal amounts (40 µg) of digitonin-solubilized mitochondrial extracts from MAFs of the
indicated genotype were separated by BNGE and immunoblotted with anti-ATP synthase subunit α (ATPase) and Succinate Dehydrogenase (SDHA)
antibodies. ATPase oligomers (Vo), dimers (Vd), monomers (Vm) and F1 are indicated. b Densitometric analysis of experiments performed as in a. Data
represent mean ± SEM of Vo+Vd (oligomeric)/total ATP synthase (Vo+Vd+Vm+ F1) from five different experiments. *p < 0.05 in a two-way ANOVA
vs. control. c Equal amounts (40 µg) of digitonin-solubilized mitochondrial extracts from MAFs of the indicated genotype were separated by BNGE and
immunoblotted with the indicated antibodies (left) or processed for ATPase activity (right). ATPase oligomers (Vo), dimers (Vd), monomers (Vm) and F1
are indicated. d, e Quantitative densitometric analysis of total ATP synthase/CII (SDHA) (d) and of oligomeric/total ATP synthase conformations (e) in
experiments as in c. Data show mean ± SEM of at least three independent experiments. *p < 0.05 in a two-way ANOVA versus EV. f Mitochondria from
MAFs of the indicated genotypes were treated with recombinant BID as indicated for 30min, lysed and equal amounts (40 µg) of digitonin-solubilized
extracts were separated by BNGE and immunoblotted with the indicated antibodies. g, h Quantitative densitometric analysis of total/CII (SDHA) (g) and of
oligomeric/total ATP synthase conformations (h) in experiments as in f. Data are normalized to untreated cells and represent mean ± SEM of at least three
independent experiments. *p < 0.05 in an unpaired two-sample Student’s t test versus untreated
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the ability of OPA1 to sustain mitochondrial electrochemical
gradient and function when respiratory chain is inhibited.
Dynamic complexomic analysis of mitochondria undergoing
cristae remodeling and OMM permeabilization is a powerful tool to
inspect HMW complexes reorganization during cristae shape
changes. This method can also identify unexpected OPA1 partners
in cristae morphogenesis, such as the MICOS components Mic60
and Mic1926 and the SLC25A solute carriers family members that
relay respiratory substrates availability to OPA1 to trigger the
orthodox to condensed cristae transition28. By comparative com-
plexomics we discovered that ATP synthase oligomers are very

































































































































































































































































































































Fig. 4 ATP synthase oligomers are reduced by cristae remodeling. a, b Mouse heart mitochondria were incubated as indicated and after 30min protein
lysates (30 µg) were separated by BNGE and Coomassie stained (a) or immunoblotted with the indicated antibody (b). c Representative color-contour
plots of spectral counts of OPA1 peptides from quantitative DiS-MS analysis of extracted mitochondrial complexes. Experiments were as in a. Numbers
indicate the bands excised for MS analysis. The rainbow color scale indicates the number of spectral counts. d, e Color-contour plot of spectral counts of F1
core components (α, β, γ, δ, OSCP, panel d) and of the FO ATPase dimerization subunit e (ATP5k) from experiments as in c. f Experiments were as in b,
except that membranes were decorated with the anti-ATPase subunit e antibody. Asterisks: cross-reactive unspecific bands. g Quantification of
experiments as in d, e. The median values of the spectral counts of the indicated ATP synthase subunits were calculated in mitochondria pooled from three
experiments performed as in a. The ratio of the median values in the dimer+oligomer region over the total forms is plotted
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A proteomic profiling of OPA1 interactors identified different
subunits of ATP synthase28, suggesting a possible mechanism for
the stabilization of the latter. Indeed, OPA1 co-
immunoprecipates with ATP synthase and both are retrieved in
high-order crosslinked complexes, where OPA1 could directly
stabilize ATP synthase. However, a reductionist approach of
purified recombinant OPA1 and ATP synthase containing pro-
teoliposomes failed to prove that OPA1 directly stimulates or
stabilizes ATP synthase oligomerization. These experiments
suggest that the cristae curvature, promoted by OPA1, might
itself stabilize ATP synthase oligomers. This effect would com-
plement that of ATP synthase dimers on membrane curvature, in

































































































































































Fig. 5 OPA1 does not directly stimulate ATP synthase oligomerization. a Purified mitochondria were treated where indicated with 10 mM EDC. After 30min
the reaction was quenched, mitochondria lysed and equal amounts (40 µg) of proteins were separated by SDS-PAGE and immunoblotted using the
indicated antibodies. Dashed box: OPA1 and ATPase cross-reactive adduct. Arrowheads: non-crosslinked OPA1 and ATPase. Bottom panels: short
exposure blots of non-crosslinked OPA1 and ATPase. b, c Mitochondrial lysates (200 µg) were immunoprecipitated with the indicated antibodies coupled
to Protein A agarose beads; bound proteins were separated by SDS-PAGE and immunoblotted using the indicated antibodies. Input was diluted 1:10.
d Representative EM image of a negatively stained proteoliposome containing rOPA1 in the lumen either in the absence (left panel) or presence (right
panel) of recombinant ATP synthase in the membrane. Arrowheads: F1 oriented towards the outside of the liposome. Scale bar, 50 nm. e Proteoliposomes
harboring ATPase and either empty or containing rOpa1 were solubilized and proteins separated by BN-PAGE. f Densitometric quantification of ATPase
composition in experiments as in e. Data are mean ± SEM of four independent experiments. g, h Representative BNGE (g) and densitometric quantification
(h) of ATPase oligomeric forms upon incubation of the indicated ratios of rOPA1 with ATP synthase (3 µg). Data are mean ± SEM of four independent
experiments. Vo: ATPase oligomers, Vd: dimers, Vm: monomers
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a feed forward loop that ultimately leads to stabilization of cristae
shape by its multiple molecular determinants.
Traditionally, ATP synthase dimerization has been regarded as
a cornerstone in cristae morphogenesis: rows of ATP synthase
dimers at the edge of the cristae maintain the orthodox structure
of the latter48,50. In yeast, genetic dimerization disruption results
in aberrant mitochondrial ultrastructure19,23,48. This organization
has also functional consequences: the ATP synthase dimers on
the cristae edge contribute to create a proton gradient sur-
rounding the enzyme24,51, ultimately favoring ATP synthesis50.
By using apoptotic and genetic manipulations, we demonstrate
that ATP synthase oligomerization is also affected by cristae
curvature: ATP synthase dimers, like supercomplexes, are desta-
bilized during cristae remodeling and when Opa1 is ablated, and
stabilized by OPA1 overexpression3.
ATP synthase dimers stabilization improves mitochondrial
ultrastructure48,52, raising the question of whether the effects of
OPA1 on cristae shape are secondary to the stabilization of ATP
synthase dimers. Ablation of ATP5k (subunit e), a supernumerary
ATP synthase subunit required to bend the IMM and enable
dimer formation, but not essential for cell growth, results in loss
of cristae tips, formation of cross-sectional septa and occasional
onion-like cristae19,24,40,41,46,53. OPA1 overexpression reverted
these shape changes, indicating that OPA1 can modulate cristae
shape independently of ATP synthase dimers that shape cristae
edges and tips23,48,50. Our genetic analysis places OPA1 upstream
also of the ATP synthase in the pathway that controls cristae
width, junctions and number26. The combination of in vivo and
in vitro experiments presented here suggest that ATP synthase

























































































































































Fig. 6 OPA1 requires ATP5k to stabilize ATP synthase oligomers. a Equal amounts (30 µg) of lysates from MAFs of the indicated genotype transfected for
48 h with the indicated shRNA were separated by SDS-PAGE and immunoblotted with the indicated antibodies (ATPase is ATP5A). b Equal amounts (40
µg) of digitonin-solubilized mitochondrial extracts from MAFs of the indicated genotype transfected with the indicated shRNAs were separated by BNGE
and immunoblotted with the indicated antibodies. c Quantitative densitometric analysis of ATPase dimer vs. total ATPase. Data are mean ± SEM of three
independent experiments performed as in b. d Representative EM micrographs of cells of the indicated genotype transfected with the indicated shRNA and
GFP and after 48 h sorted for GFP+ and processed for EM. Boxed areas are magnified 12× in the bottom images. Scale bars: 500 nm; 20 nm in bottom
magnifications. e–g Morphometric analysis of cristae maximal width (e), number of cristae per mitochondrion (f) and cristae junctions per cristae (g) in
experiments as in d. At least 30 mitochondria per experimental condition were analyzed. Mean values ± SEM of three independent experiments are shown.
*p < 0.05 in a two-way ANOVA versus control (e) or paired two-sample Student’s t test versus scramble shRNA (shScr) (f, g)
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favoring superassembly in regions of negative curvature generated
by OPA1. Conversely, when ATP synthase dimerization was
genetically hampered, OPA1 failed to preserve mitochondrial
function, indicating a reciprocal functional and structural
crosstalk.
Opa1tg cells are protected from CIII inhibition in galactose-
supplemented media, where the contribution of glycolysis to
membrane potential maintenance is marginal7,54,55. Mechan-
istically, OPA1 sustains mitochondrial function by stimulating
ATPase reverse activity, which is increased in Opa1tg mitochon-
dria: pharmacological inhibition of ATPase activity abolishes the
protective function of OPA1. Similarly, genetic inhibition of ATP
synthase dimerization abolishes the ATPase activity stimulation
and the maintenance of mitochondrial function by OPA1. In this
context, it is conceivable that the reduced matrix acidification
observed in Opa1tg MAFs upon complex III inhibition prevents
the binding of the ATPase inhibitor IF1 to the enzyme, which
optimally occurs at pH 6.544, thereby delaying a IF1-mediated
ATPase inhibition and cristae shape stabilization52,56.
Our work unravels a bioenergetic mechanism accounting for
OPA1 protection against mitochondrial failure and suggests that
its overexpression might be beneficial to sustain bioenergetics in
mitochondriopathies57–61, germline defects62 and neurodegen-
eration63, whereas OPA1 might be a target to correct oxidative
phosphorylation changes in cancer64–66.
Methods
Cell culture and transfection. WT, Opa1flx/flx, Opa1tg MAFs were generated in the
Scorrano lab and grown in DMEM supplemented with 10% FBS3. Unless otherwise
stated, glucose in the medium was substituted with 0.9 mg/ml galactose to force
ATP production by the respiratory chain7.
Transient transfection with scramble or ATP5k (F1Fo-ATP synthase sub. e;
NM_007507.2) shRNA encoding SureSilencing® plasmids (Qiagen, KM31364H,
plasmid #3) were performed using Transfectin (Biorad). Following overnight
transduction, the rate of GFP expression was typically around 60–70%, as
determined by flow cytometry. Co-transfections of SureSilencing® shRNA plasmids
or pcDNA3.1 vectors harboring WT or mutant tBID cDNAs were performed at a
3:1 ratio to empty pIRES2-eGFP plasmid (Clontech) or vectors encoding for
pSypHer-dMito34 or wt (AT1.03) or inactive (AT1.03R122K/R126K) ATeam38. Acute









































































































































































Fig. 7 OPA1 requires ATP5k to protect from mitochondrial dysfunction. a Representative pseudocolor-coded frames from real time imaging of TMRM
fluorescence in MAFs of the indicated genotype transfected with the indicated shRNA. Where indicated, cells were incubated with antimycin A (AA) (2 µM
for 25min). Scale bar, 20 µm. b, c Quantitative analysis of mitochondrial TMRM fluorescence ratio in experiments as in a. Where indicated, cells were
treated with 2 µM FCCP. Data are mean ± SEM of at least four independent experiments. d Pseudocolor-coded frames of mtATeam FRET fluorescence ratio
in cells of the indicated genotype. Where indicated, cells were treated for 20min with AA (10 µM). The rainbow indicates the pseudocolor scale. Scale bar,
20 µm. e Mean ± SEM of maximal mtATeam fluorescence ratio slopes in at least three independent experiments as in (d). *p < 0.05 in an unpaired two-
sample Student’s t test. versus scramble shRNA (shScr). fMAFs of the indicated genotype were cotransfected with GFP and the indicated shRNA and after
72 h were treated with AA (5 µM, 6 h). Data are mean ± SEM of three independent experiments. *p < 0.05 in a two-way ANOVA test versus shScr
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Cre-recombinase under the control of a PGK promoter (pPGK-Puro, Addgene)
and subjected to analysis after 48 h incubations.
Real time imaging. For live imaging, cells (5 × 104) seeded onto 24-mm round
glass coverslips and incubated in Ca2+/Mg2+ supplemented HEPES buffer (HBSS,
Invitrogen) were transferred onto the stage of an Olympus IX81 inverted micro-
scope (Melville, NY) equipped with a CellR imaging system and a beam-splitter
optical device (Multispec Microimager; Optical Insights). Images were acquired
using a 40×, 1.4 NA objective (Olympus) and the CellR software. Analysis of
fluorescence was performed following background subtraction over mitochondrial
regions of interests (ROIs), using the multi-measure plug-in of Image J (NIH).
Representative still frames are pseudocolor coded.
For real time imaging of mitochondrial ΔpH, cells (5 × 104) seeded onto 24-mm
round glass coverslips were transfected with pSypHer-dMito34 and analyzed after
24 or 48 h after transfection to express Cre recombinase. Ratiometric images of the
535-emission fluorescence were acquired every 10 s by alternate excitation of cells
at 430 and 500 nm for 100 ms. Mean fluorescence ratios of selected ROIs matching
mitochondria were measured and expressed as mtSypHer (430/500 nm) ratios.
Mitochondrial ATP content was determined by FRET image analysis of cells
transfected with pcDNA-ATeam1.0338. Sequential images of the 525 and 475 nm
fluorescence emission after alternate excitation at 435 nm for 100 ms were acquired
every 30 s.
For TMRM fluorescence analysis, sequential images were acquired every 30 s11.
Transmission electron microscopy. Electron microscopy (EM) imaging of cells
was performed as described26 on a Tecnai G2 (FEI) transmission electron
microscope operating at 100 kV. Images were captured using a Veleta (Olympus
Imaging System) digital camera (pixel size 13 × 13 µm; pixel size at a 46,000X
magnification with screen magnification of 3 × 0.1 × 0.1 nm). For morphometric
analysis of mitochondrial cristae, performed in a blind fashion on at least five
mitochondria/cell from six randomly selected cells (n= 3 independent experi-
ments), maximal cristae width was measured using the ImageJ Multimeasure plug-
in3; the number of horizontal cristae and cristae junctions were quantified
manually.
Immunoblotting. For SDS-PAGE experiments, proteins (30–40 µg) were separated
on Any-KD (BioRad) polyacrilamide precasted gels, transferred onto PVDF
membranes (BioRad) and probed using the indicated antibodies and isotype
matched HRP-conjugated secondary antibodies. The following primary antibodies
were employed at 1:1000 dilution: OPA1 (BD, #612607), ATP5A (ab14748),
ATP5B (ab14705), IF1 (ab110277), SDHA (ab14715), ATP5 subunit e (ab54879)
from Abcam; ACTIN (Chemicon) was used at a 1:30000 dilution (MAB1501
Millipore). Densitometry was performed using ImageJ gel measure tool and ana-
lyzing the optical density of selected ROIs containing ATP synthase dimers,
monomers and F1. Uncropped scans of relevant blots are included in Supple-
mentary Figure 9.
Isolated mitochondria assays. Mitochondria were extracted from cells grown in
500 cm2 dishes67. After isolation, mitochondrial protein concentration was deter-
mined by Bradford assay (BioRad) and 0.5 mg/ml protein were incubated in
Experimental Buffer (EB: 150 mM KCl, 10 mM Tris MOPS, 10 µM EGTA-Tris, 1
mM KHPO4, 5 mM glutamate, 2.5 mM malate) and further incubated where
indicated with 10 pmol/mg cBID for 30 min at room temperature.
Blue-native polyacrylamide gel electrophoresis. Isolated mitochondria were
resuspended (0.5 mg/ml) in NativePAGE Sample buffer (Invitrogen) containing
1.1% (w/V) digitonin (Sigma) and protease-inhibitor cocktail (Sigma). After 5 min
on ice, the lysate was spun at 20,000xg for 30 min at 4 °C. G250 (5%, 1 µl/100 µg
protein, Invitrogen) was added to the supernatant 30–40 µg of protein were loaded
onto a 3–12% native precast gel (Invitrogen).
Protein crosslinking. Where indicated, mitochondrial extracts were crosslinked in
the presence of the zero-length crosslinker EDC11. Proteins (50 µg) were incubated
for 30 min at 37 °C in PBS supplemented with 10 mM EDC. The reaction was
quenched by adding 15 mM dithiothreitol (DTT) and proteins were separated by
SDS-PAGE after 15 min.
Immunoprecipitation. Isolated mitochondria were lysed in 150 mM NaCl, 25 mM
Tris-Cl pH 7.4, 1 mM EDTA, 5% glycerol, 0.1% Triton X-100 in the presence of
Protease Inhibitory Cocktail (PIC) (Sigma). Lysates (250 μg) were precleared on 20
μl of Protein-A agarose beads (Roche) for 30 min at 4 °C and subsequently
immunoprecipitated with protein-A agarose beads coupled with the indicated
antibodies in lysis buffer overnight at 4 °C26. The immunoprecipitated material was
separated by SDS-PAGE.
Liposomes preparation. Liposomes were prepared from purified soybean asolectin
(L-α-phosphatidylcholine, Sigma). Lipids were dissolved in chloroform (5 mg/ml)
until a homogeneous mixture was obtained; the solvent was then evaporated on a
nitrogen stream to yield a thin lipids layer on a glass tube bottom. The lipid film
was thoroughly dried by placing the tube on a vacuum pump overnight to remove
residual chloroform. To obtain large multilamellar vesicles (LMV) the lipid film
was hydrated with 1 mL buffered solution (150 mM KCl, 10 mM Hepes, pH 7.4),
containing where indicated 20 µg of purified recombinant OPA1 (rOPA1), and
gently agitated at room temperature. When rOPA1 was added, liposomes were
then centrifuged at 30,000×g for 5 min and resuspended in fresh buffer devoid of
rOPA1. LMV were then downsized to liposomes (large unilamellar vesicles, LUV)
by extrusion through a polycarbonate filter with a pore size of 100 nm (Avanti
Polar Lipids).
Intact mammalian F1FO-ATP synthase was purified from beef heart
mitochondria as described68 and inserted into freshly made liposomes by direct
incubation of the protein (20 µg) with the liposomes solution for 30 min at 4 °C. To
remove non-inserted F1FO-ATP synthase complexes proteoliposomes were pelleted
by centrifugation at 30,000×g for 5 min and resuspended in buffer.
Negative staining EM. Twenty-five µl of containing freshly prepared proteoli-
posomes suspension were placed on a 400-mesh holey film grid, stained with 1%
UO2(CH3COO)2 and observed with a Tecnai G2 (FEI) transmission electron
microscope operating at 100 kV. Images were captured using a Veleta (Olympus
Imaging System) digital camera.
Blue native PAGE and silver staining of recombinant proteins. Purified ATP
synthase was supplemented with Coomassie Blue G-250 (Serva) and applied to 1D
3–12% polyacrylamide gradient BNE (Invitrogen). After electrophoresis, proteins
were eluted from BNE gels overnight as follows. Bands corresponding to mono-
mers of F-ATP synthase were excised and diluted with 25 mM tricine, 7.5 mM Bis-
Tris, and 1% (w/V) n-heptyl β-D-thioglucopyranoside, pH 7.0 supplemented with
8 mM ATP-Tris, and 10 mM MgSO4. Samples were incubated at 4 °C, centrifuged
at 20,000 × g for 20 min at 4 °C, and supernatants were inserted into liposomes as
described above.
Liposomes were then solubilized with 4% (wt/vol) freshly prepared digitonin,
supplemented with Coomassie Blue G-250 (Serva), and loaded in 2D-BNE followed
by silver staining. Gels were fixed overnight with formaldehyde, rinsed with
ethanol, and pretreated with a solution of 0.8 mM Na2S2O3; gels were then stained
with 11.2 mM AgNO3 for 20 min, and then with 0.6 M Na2CO3 for the time
required for the bands to be revealed.
Production and purification of recombinant OPA1. OPA1 mouse transcript
variant 2 (NM_133752) was amplified from position 502 to the stop codon to
produce recombinant OPA1 (rOPA1) lacking the N-terminal transmembrane
domain. The PCR product was cloned into pET21+ (Novagen) which adds a His-
tag to the C-terminus of the encoded protein and expressed in E. coli. Protein
production was induced with 0.5 μM IPTG for 20 h at 18 °C. E. coli were collected
by centrifugation and the pellet was resuspended in lysis buffer (40 mM Hepes/
KOH, 500 mM NaCl, 10% glycerol, 5 mM MgCl2, 5 mM β-mercaptoethanol, 0.5%
Triton-X-100, 2% Tween-20, 1 mM PMSF, 20 mM Imidazole, Roche protease-
inhibitor cocktail, pH 8.0). Cells were lysed by sonication and cell debris was
removed by centrifugation at 14,000xg for 45 min, 4 °C. rOPA1 was purified by Ni-
NTA batch chromatography. Prior to elution, beads were washed with 1 mM ATP
and 10 mM MgCl2 in lysis buffer for 30 min at room temperature followed by an
intermediate washing step in wash buffer (40 mM Hepes/KOH, 300 mM NaCl,
0.05% Triton-X-100, 5 mMMgCl2, 5 mM β-mercaptoethanol, 10% glycerol, 20 mM
Imidazole, pH 8.0). rOPA1 was eluted with increasing concentrations of imidazole
in elution buffer (40 mM Hepes/KOH, 0.05% Triton-X-100, 5 mM β-mercap-
toethanol, 10% glycerol, pH 7.4). Imidazole was removed by dialysis and the
protein was concentrated in storage buffer (40 mM Hepes/KOH, 0.05% Triton-X-
100, 0.3 mM TCEP, 10% glycerol) and stored at -80 °C until use.
In-gel ATPase activity assay. ATPase in-gel activity was measured directly in the
gel by incubating it for 2 h in a solution containing 35 mM Tris, 270 mM glycine,
14 mM MgSO4, 0.2% Pb(NO3)2, and 8 mM ATP, pH 7.869,70.
BNGE based semi-quantitative proteomic analysis. Mass spectrometry analysis
of mitochondrial complexes from mouse CD1 hearts was performed as indicated26.
False discovery rate (FDR) of identification was controlled as described by the
algorithm Dxtractor. Median values of all identified ATP synthase subunits and
representative color-contour plots of spectral counts of OPA1 peptides, core F1
ATP synthase subunits and FO complex subunit e required for dimerization were
considered for analysis.
Cell death assays. For cell death analysis, 3.5 × 103 cells/cm2 of the indicated
genotype were co-transfected with SureSilencing® shRNA and pIRES2-eGFP
plasmids (3:1 ratio). After 48 h, the medium was replaced with galactose-
supplemented DMEM and after 24 h cells were treated with 5 µM antimycin A for
6 h. Cell death was assessed by flow cytometry detection (FACSCalibur) of double
Annexin-V-APC/PI positive events from the transfected GFP+ cell population3.
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Statistical analysis. Results are expressed as the mean ± SEM values of the indi-
cated number (n) of independent experiments. Individual data points are overlaid
on the bar graphs. Statistical significance was determined by Student's t test or
ANOVA between the indicated samples. P values are indicated in the legends and
P < 0.05 was considered significant.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request. The uncropped blots can
be found in Supplementary Figure 9.
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